The global custom antibody market size is calculated at USD 211.55 million in 2025 and is forecasted to reach around USD 481.76 million by 2034, accelerating at a CAGR of 9.59% from 2025 to 2034. The North America custom antibody market size surpassed USD 88.69 million in 2024 and is expanding at a CAGR of 9.59% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Custom Antibody Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Custom Antibody Market, by Type
8.1.1. Monoclonal Antibodies
8.1.1.1. Market Revenue and Forecast
8.1.2. Polyclonal Antibodies
8.1.2.1. Market Revenue and Forecast
8.1.3. Recombinant Antibodies
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast
9.1. Custom Antibody Market, by Service
9.1.1. Antibody Development
9.1.1.1. Market Revenue and Forecast
9.1.2. Antibody Production & Purification
9.1.2.1. Market Revenue and Forecast
9.1.3. Antibody Fragmentation & Labeling
9.1.3.1. Market Revenue and Forecast
10.1. Custom Antibody Market, by Source
10.1.1. Mice
10.1.1.1. Market Revenue and Forecast
10.1.2. Rabbit
10.1.2.1. Market Revenue and Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Forecast
11.1. Custom Antibody Market, by Application
11.1.1. Oncology
11.1.1.1. Market Revenue and Forecast
11.1.2. Infectious Diseases
11.1.2.1. Market Revenue and Forecast
11.1.3. Neurology
11.1.3.1. Market Revenue and Forecast
11.1.4. Stem Cells
11.1.4.1. Market Revenue and Forecast
11.1.5. Immunology
11.1.5.1. Market Revenue and Forecast
11.1.6. Cardiovascular Diseases
11.1.6.1. Market Revenue and Forecast
11.1.7. Others
11.1.7.1. Market Revenue and Forecast
12.1. Custom Antibody Market, by End-use
12.1.1. Pharmaceutical & Biotechnology Companies
12.1.1.1. Market Revenue and Forecast
12.1.2. Academic & Research Institutes
12.1.2.1. Market Revenue and Forecast
12.1.3. CRO
12.1.3.1. Market Revenue and Forecast
12.1.4. Hospitals and Clinics
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type
13.1.2. Market Revenue and Forecast, by Service
13.1.3. Market Revenue and Forecast, by Source
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End-use
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type
13.1.6.2. Market Revenue and Forecast, by Service
13.1.6.3. Market Revenue and Forecast, by Source
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End-use
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Type
13.1.7.2. Market Revenue and Forecast, by Service
13.1.7.3. Market Revenue and Forecast, by Source
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End-use
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type
13.2.2. Market Revenue and Forecast, by Service
13.2.3. Market Revenue and Forecast, by Source
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End-use
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type
13.2.6.2. Market Revenue and Forecast, by Service
13.2.6.3. Market Revenue and Forecast, by Source
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End-use
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type
13.2.9.2. Market Revenue and Forecast, by Service
13.2.9.3. Market Revenue and Forecast, by Source
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End-use
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type
13.2.12.2. Market Revenue and Forecast, by Service
13.2.12.3. Market Revenue and Forecast, by Source
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End-use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type
13.2.14.2. Market Revenue and Forecast, by Service
13.2.14.3. Market Revenue and Forecast, by Source
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End-use
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type
13.3.2. Market Revenue and Forecast, by Service
13.3.3. Market Revenue and Forecast, by Source
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End-use
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type
13.3.6.2. Market Revenue and Forecast, by Service
13.3.6.3. Market Revenue and Forecast, by Source
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End-use
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type
13.3.8.2. Market Revenue and Forecast, by Service
13.3.8.3. Market Revenue and Forecast, by Source
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End-use
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type
13.3.10.2. Market Revenue and Forecast, by Service
13.3.10.3. Market Revenue and Forecast, by Source
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End-use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type
13.3.11.2. Market Revenue and Forecast, by Service
13.3.11.3. Market Revenue and Forecast, by Source
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End-use
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type
13.4.2. Market Revenue and Forecast, by Service
13.4.3. Market Revenue and Forecast, by Source
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End-use
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type
13.4.6.2. Market Revenue and Forecast, by Service
13.4.6.3. Market Revenue and Forecast, by Source
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End-use
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type
13.4.8.2. Market Revenue and Forecast, by Service
13.4.8.3. Market Revenue and Forecast, by Source
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End-use
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type
13.4.10.2. Market Revenue and Forecast, by Service
13.4.10.3. Market Revenue and Forecast, by Source
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End-use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type
13.4.11.2. Market Revenue and Forecast, by Service
13.4.11.3. Market Revenue and Forecast, by Source
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End-use
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type
13.5.2. Market Revenue and Forecast, by Service
13.5.3. Market Revenue and Forecast, by Source
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End-use
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type
13.5.6.2. Market Revenue and Forecast, by Service
13.5.6.3. Market Revenue and Forecast, by Source
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End-use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type
13.5.8.2. Market Revenue and Forecast, by Service
13.5.8.3. Market Revenue and Forecast, by Source
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End-use
14.1. GenScript
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. LifeSpan BioSciences, Inc
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Labcorp Drug Development
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Abmart
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. YenZym Antibodies, LLC.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Kaneka Eurogentec S.A.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Bio-Rad Laboratories, Inc
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Abcam plc
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Creative Diagnostics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Thermo Fisher Scientific Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample